Personalized brain circuit scores define depression and anxiety biotypes

In a study published in Nature Medicine, researchers used fMRI data to define six depression and anxiety biotypes based on personalized brain circuit dysfunction scores. The biotypes were effective in predicting responses to pharmacotherapy and behavioral therapy, with distinct symptom profiles and cognitive test performances. Tailoring treatments to these biotypes could improve outcomes for patients with anxiety and depression.